Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection.
Stefic K, Novelli S, Mahjoub N, Seng R, Molina JM, Cheneau C, Barin F, Chaix ML, Meyer L, Delaugerre C; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) PRIMO Study Group. Stefic K, et al. Among authors: mahjoub n. J Infect Dis. 2018 May 5;217(11):1793-1797. doi: 10.1093/infdis/jiy120. J Infect Dis. 2018. PMID: 29509924
Identifying patients infected with hepatitis B virus in sub-Saharan Africa: potential for misclassification.
Boyd A, Maylin S, Moh R, Gabillard D, Menan H, Mahjoub N, Danel C, Anglaret X, Eholié SP, Girard PM, Zoulim F, Delaugerre C, Lacombe K; ANRS 12240 VarBVA study. Boyd A, et al. Among authors: mahjoub n. Diagn Microbiol Infect Dis. 2015 Nov;83(3):248-51. doi: 10.1016/j.diagmicrobio.2015.07.009. Epub 2015 Jul 18. Diagn Microbiol Infect Dis. 2015. PMID: 26283522
Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
Boyd A, Maylin S, Moh R, Mahjoub N, Gabillard D, Eholié SP, Danel C, Anglaret X, Zoulim F, Girard PM, Delaugerre C, Lacombefor K; ANRS 12240 VarBVA study. Boyd A, et al. Among authors: mahjoub n. J Gastroenterol Hepatol. 2016 Mar;31(3):634-44. doi: 10.1111/jgh.13156. J Gastroenterol Hepatol. 2016. PMID: 26313291
Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trial.
Fonsart J, Saragosti S, Taouk M, Peytavin G, Bushman L, Charreau I, Hance A, Goldwirt L, Morel S, Mammano F, Loze B, Capitant C, Clavel F, Mahjoub N, Meyer L, Anderson PL, Delaugerre C, Molina JM. Fonsart J, et al. Among authors: mahjoub n. J Antimicrob Chemother. 2017 Feb;72(2):478-485. doi: 10.1093/jac/dkw412. Epub 2016 Sep 28. J Antimicrob Chemother. 2017. PMID: 28073964 Clinical Trial.
Assessment of HIV Screening Tests for Use in Preexposure Prophylaxis Programs.
Delaugerre C, Antoni G, Mahjoub N, Pialoux G, Cua E, Pasquet A, Hall N, Tremblay C, Cotte L, Capitant C, Chaix ML, Meyer L, Molina JM; IPERGAY Study Group. Delaugerre C, et al. Among authors: mahjoub n. J Infect Dis. 2017 Aug 1;216(3):382-386. doi: 10.1093/infdis/jix297. J Infect Dis. 2017. PMID: 28666370
Detectable HIV-RNA in semen of HIV controllers.
Chaix ML, Boufassa F, Meyzer C, Leruez-Ville M, Mahjoub N, Nere ML, Genet P, Duvivier C, Lascoux-Combes C, Lambotte O, Ghosn J. Chaix ML, et al. Among authors: mahjoub n. PLoS One. 2017 Aug 16;12(8):e0183376. doi: 10.1371/journal.pone.0183376. eCollection 2017. PLoS One. 2017. PMID: 28813503 Free PMC article.
Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load.
Wirden M, Larrouy L, Mahjoub N, Todesco E, Damond F, Delagreverie H, Akhavan S, Charpentier C, Chaix ML, Descamps D, Calvez V, Marcelin AG. Wirden M, et al. Among authors: mahjoub n. J Clin Virol. 2017 Nov;96:49-53. doi: 10.1016/j.jcv.2017.09.007. Epub 2017 Sep 20. J Clin Virol. 2017. PMID: 28950186
Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals.
Lê MP, Belarbi L, Chaix ML, Dulioust E, Mahjoub N, Salmon D, Viard JP, Duvivier C, Peytavin G, Launay O, Ghosn J. Lê MP, et al. Among authors: mahjoub n. J Antimicrob Chemother. 2017 Nov 1;72(11):3167-3171. doi: 10.1093/jac/dkx275. J Antimicrob Chemother. 2017. PMID: 28961979
Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study).
Lambert-Niclot S, Grude M, Chaix ML, Charpentier C, Reigadas S, Le Guillou-Guillemette H, Rodallec A, Amiel C, Maillard A, Dufayard J, Mourez T, Mirand A, Guinard J, Montes B, Vallet S, Marcelin AG, Descamps D, Flandre P, Delaugerre C, Morand-Joubert L; ANRS AC-11 Resistance Group. Lambert-Niclot S, et al. J Antimicrob Chemother. 2018 Aug 1;73(8):2147-2151. doi: 10.1093/jac/dky142. J Antimicrob Chemother. 2018. PMID: 29718247
Effect of hepatitis B virus (HBV) surface-gene variability on markers of replication during treated human immunodeficiency virus-HBV infection in Western Africa.
Boyd A, Moh R, Maylin S, Abdou Chekaraou M, Mahjoub N, Gabillard D, Anglaret X, Eholié SP, Danel C, Delaugerre C, Zoulim F, Lacombe K; ANRS 12240 VarBVA study. Boyd A, et al. Among authors: mahjoub n. Liver Int. 2019 Feb;39(2):280-289. doi: 10.1111/liv.13975. Epub 2018 Oct 17. Liver Int. 2019. PMID: 30257068 Free article.
52 results